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Abstract
Neuroscience is at a crossroads. Great effort is being invested into deciphering specific neural
interactions and circuits. At the same time, there exist few general theories or principles that
explain brain function. We attribute this disparity, in part, to limitations in current methodologies.
Traditional neurophysiological approaches record the activities of one neuron or a few neurons at
a time. Neurochemical approaches focus on single neurotransmitters. Yet, there is an increasing
realization that neural circuits operate at emergent levels, where the interactions between hundreds
or thousands of neurons, utilizing multiple chemical transmitters, generate functional states.
Brains function at the nanoscale, so tools to study brains must ultimately operate at this scale, as
well. Nanoscience and nanotechnology are poised to provide a rich toolkit of novel methods to
explore brain function by enabling simultaneous measurement and manipulation of activity of
thousands or even millions of neurons. We and others refer to this goal as the Brain Activity
Mapping Project. In this Nano Focus, we discuss how recent developments in nanoscale analysis
tools and in the design and synthesis of nanomaterials have generated optical, electrical, and
chemical methods that can readily be adapted for use in neuroscience. These approaches represent
exciting areas of technical development and research. Moreover, unique opportunities exist for
nanoscientists, nanotechnologists, and other physical scientists and engineers to contribute to
tackling the challenging problems involved in understanding the fundamentals of brain function.
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The Brain Activity Mapping (BAM) Project1–5 has three goals in terms of building tools for
neuroscience capable of (1) measuring the activity of large sets of neurons in complex brain
circuits, (2) computationally analyzing and modeling these brain circuits, and (3) testing
these models by manipulating the activities of chosen sets of neurons in these brain circuits.
As described below, many different approaches can, and likely will, be taken to achieve
these goals as neural circuits of increasing size and complexity are studied and probed.
The BAM project will focus both on dynamic voltage activity and on chemical
neurotransmission. With an estimated 85 billion neurons, 100 trillion synapses, and 100
chemical neurotransmitters in the human brain,6 this is a daunting task. Thus, the BAM
project will start with model organisms, neural circuits (vide infra), and small subsets of
specific neural circuits in humans.
Among the approaches that show promise for the required dynamic, parallel measurements
are optical and electro-optical methods that can be used to sense neural cell activity such as
Ca2+,7 voltage,8–10 and (already some) neurotransmitters;11 electrophysiological approaches
that sense voltages and some electrochemically active neurotransmitters;12–17 next-
generation photonics-based probes with multifunctional capabilities;18 synthetic biology
approaches for recording histories of function;19–21 and nanoelectronic measurements of
voltage and local brain chemistry.22–39 We anticipate that tools developed will also be
applied to glia and more broadly to nanoscale and microscale monitoring of metabolic
processes.
Entirely new tools will ultimately be required both to study neurons and neural circuits with
minimal perturbation and to study the human brain. These tools might include “smart”,
active nanoscale devices embedded within the brain that report on neural circuit activity
wirelessly and/or entirely new modalities of remote sensing of neural circuit dynamics from
outside the body. Remarkable advances in nanoscience and nanotechnology thus have key
roles to play in transduction, reporting, power, and communications.
One of the ultimate goals of the BAM project is that the knowledge acquired and tools
developed will prove useful in the intervention and treatment of a wide variety of diseases of
the brain, including depression, epilepsy, Parkinson’s, schizophrenia, and others. We note
that tens of thousands of patients have already been treated with invasive (i.e., through the
skull) treatments. While we hope to reduce the need for such measures, greatly improved
and more robust interfaces to the brain would impact effectiveness and longevity where such
treatments remain necessary.
Neuroscience at a Crossroads
Understanding how the brain works is one of the greatest challenges facing science and
engineering. After more than a century of sustained progress in biological sciences and
medicine, one could argue that mankind has made significant advances in our understanding
of how biological systems operate and how different parts of the body function and, when
damaged, generate disease. At the same time, a comprehensive understanding of the brain
remains an elusive, distant frontier. To arrive at a general theory of brain function would be
an historic event, comparable to inferring quantum theory from huge sets of complex spectra
and inferring evolutionary theory from vast biological field work. Not only would a theory
of brain function be a fundamental advance in biology, but it would enable understanding of
the pathophysiology of neurological and neuropsychiatric diseases. Many of these
devastating brain-based pathologies have neither cures nor effective treatments, in large part
because it is difficult to provide a treatment for a dysfunctional organ when one does not
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know how it works. Finally, the historic importance of generating a theory of brain function
is highlighted by the fact that as humans, more than any other species, we are defined by the
higher cognitive abilities generated by our brains. Thus, scientific understanding of our
brains will enable deeper knowledge of ourselves and of our minds.
Neuroscientists have worked on this key problem for the last century, and yet a
comprehensive theory of brain function remains elusive. Enormous progress has been made
in understanding the molecular and cellular components of neural circuits in humans and
experimental animals. One goal to this end is to drive the development and testing of
theories of brain function that require better spatial and temporal sampling and intervention
than is presently possible. Greater precision and parallelism in electrical and chemical
sensing, as well as the ability to excite and to probe neural circuits actively, as proposed
here, would bridge the nanoscale to the microscale to the macroscale and would complement
ongoing connectional mapping of brain circuits.
Need for High-Resolution, Network-Level Brain Activity Mapping
Approaches
There has been remarkable progress in the ability to ascribe specific functional roles to
specific neuroanatomical regions, axonal tracts, cells, synapses, and molecules. For
example, large-scale maps of gene expression in the brain, such as the Allen Brain Atlas40
or GENSAT Project41 provide enormous insight into the brain’s architecture at the genetic
level with precise anatomical resolution. However, no comparably high-resolution maps of
brain-wide neuronal activity are available. On one hand, noninvasive mapping techniques
such as functional magnetic resonance imaging (fMRI), positron emission tomography
(PET), and electroencephalography (EEG) reveal a wealth of information about functional
brain organization and connectivity.42–44 These methods offer coarse-grain views that do
not fully capture the underlying networks’ properties. On the other hand, our ability to
perceive and to ponder the cosmos, to remember information, to feel pleasure from daily
experiences, to make decisions—and deficits in performing some of these tasks when faced
with disease—involves a complex interplay of large, distributed neuronal populations
signaling on millisecond time scales. Science has barely scratched the surface of this fast,
network-level regime. The huge potential payoff for understanding the brain and diagnosing
and treating neurological disorders means that techniques for measuring brain activity are
scaling up at a rapid pace.45
Thanks in part to these advances, the development of technology to enable a paradigm shift
from experiments that routinely record tens of neurons at a time to experiments that can
record millions of cells is important and timely. From a computational perspective, it is
obvious that information processing in the brain relies on a cascade of events,46 and
sampling these events a few cells at a time, as has been the norm in neuroscience, cannot
capture the emergent properties of such a deeply interconnected network as the brain. The
search for spatiotemporal patterns and correlations in spike trains of recorded neurons can be
enormously enhanced by raising the number (N) of simultaneously accessible units.22,47 For
example, assuming a uniform connection probability, the likelihood of finding synaptically
coupled cells increases quadratically with N. Testing the functional implications of small-
world models of interacting neural networks48 would likewise benefit from having access to
greater N. Molecular-level analyses of cellular organization reveal the immense
heterogeneity of neuronal subpopulations. Many of these subpopulations—such as
cholinergic interneurons in the striatum49—represent only a small fraction of cells in a given
area, yet they are known to play important roles in regulating behavior.50 This suggests that
in order to sample several of these rare but important units reliably, so as to understand their
function in vivo, large-scale measurements of neuronal activity are necessary. Further,
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because the brain is composed of many specialized neuron types that perform specific
functions within microcircuits, techniques must be developed that enable both the identities
and activities of neurons to be measured.
In spite of this progress, why does neuroscience still lack a general theory? One contributor
is the sheer complexity of brain circuits. Even in the simplest organisms, nervous systems
are composed of circuits built with many different subtypes of neurons connected in patterns
of prohibitive complexity. These “impenetrable jungles where many investigators have lost
themselves”, as Ramon y Cajal, one of the earliest neuroanatomists termed them,51 have
difficult experimental access, and the sheer diversity of neural circuits and their components
makes it difficult to draw strong conclusions or generalizations on which to build general
theories. In fact, neuroscientists have traditionally analyzed the structure and function of
these circuits one neuron at a time, using electrical recordings from individual neurons, for
example, while an experimental animal is performing a specific behavior. At the same time,
any neural circuit is composed of thousands or hundreds of thousands of neurons, which are
heavily interconnected. Because of these structures, it is likely that neural circuits operate at
an emergent level, one generated by the functional interactions between large populations of
neurons. Thus, measurements from individual neurons would not give insight into function,
just as one cannot understand the function of a building by analyzing the molecular
structures of its bricks. In fact, emergent properties have been encountered in many areas of
science and engineering. The laws of thermodynamics, statistical mechanics, and the
generation of magnetic properties are examples of fields of science that require
understanding of emergent phenomena that result from interactions across many individual
particles. The goal of the BAM project is to provide the data sets and the critical tests to
enable the development and testing, respectively, of theories and models of neural circuits
and brain function.
To elucidate emergent properties, neuroscientists will need novel techniques that enable
simultaneous monitoring of the activities of many or all of the cells in neural circuits. While
whole-brain imaging techniques, such as fMRI, enable bird’s eye views of the activity of
brain areas, they lack the spatial and temporal resolution required to provide functional
information on individual neurons and their interactions. New techniques are needed, and
while neuroscientists are generating many novel approaches, we believe that nanoscience
and nanotechnology are ideally poised to make fundamental contributions to this problem
and to help generate the toolkits of methods that could be used to measure and to manipulate
the activities of increasingly larger sets of neurons in complex and widespread neural
circuits.
The Nanoscience and Nanotechnology Revolution
The nanoscience and nanotechnology revolution began with the ability to “see” at the atomic
scale with the inventions of the scanning tunneling microscope, the atomic force
microscope, and related tools.52–55 It then progressed with the ability to manipulate
individual atoms and molecules, as well as to direct assemblies of molecules into precise
structures.56–60
In the years since, remarkable progress has been made in developing novel materials, tools,
and methods that have opened up new possibilities across science, engineering, and
medicine. Some progress has already been made toward addressing problems in
neuroscience via nanotechnology.
In the past decade, substantial investments have been made through the National
Nanotechnology Initiative in the United States and similar programs in countries around the
world. Support continues in the hope that the dramatic advances we have seen in
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nanoscience and nanotechnology will continue and will now be applied to other fields of
science, engineering, and medicine, as well as to manufacturing and commercialization.61
Top-Down (Lithographic) Devices
Miniaturization through lithographic and other means has been a continuing trend fueled
largely by the need to develop ever more functional systems. Over the past decades, these
systems have catered to the needs of consumer electronics, with the opportunities of using
microchips to control and to interpret information on massive scales. More recently, this
trend has been driven by our need to be connected and to communicate, leading to more
portable systems in which size, weight, and power are at a premium. The same trend that
enables the miniaturization of electronic and radio frequency communications systems has
also influenced optical and fluidic systems, with the emergence of printed silicon photonics
and microfluidics that can decrease the sizes of lasers, modulators, and detectors, as well as
pumps, valves, and mixers. As a general rule, the size of printed systems has been reduced
by a factor of 100 × in volume every 10 years (Bell’s Law).62 These reductions in system
size correspond to improvements in the fidelity of lithographic processes, enabling the
geometric doubling in the number of individual devices on a chip every 18 months (Moore’s
Law).63 It could be argued that Moore’s Law is driven by the “real-estate” value on the chip,
which in the case of silicon electronics has remained constant over the past 40 years, at a
cost of approximately $5/cm2.
Miniaturization in electronic devices has led to the ability to create structures with 22 nm
lateral width over 300 mm wafers, produced on commercial scales at approximately 20
wafers/h. Individual transistors are now 200 nm in size, and amplification circuits are on the
order of micrometers. For the specific application of studying the brain, it is now possible to
contemplate using these capabilities to increase the numbers of neurons interrogated by
reducing the sizes of electrophysiological probes and to develop systems that can manage
large amounts of data accumulated and/or transmitted during such measurements. This
dramatic reduction in the size of electronic systems enables the construction of devices that
can be implanted with less intrusiveness and enables the development of small
electrophysiological tools to measure and to control individual neurons. Simultaneously, this
miniaturization is associated with increases in the operating frequencies of electronics and
reductions in the sizes of antennas and power required, resulting in smaller communications
systems.
Indeed, systems being developed for future use in communications may be of great value for
neuroscience, as well. Multiferroic antennas are one example in which devices can be 1000
× smaller than conventional antennas and may be able to be powered remotely.64 More
broadly, ultrasmall nanoelectronic chips might be used to combine modalities of detection of
signals from operating neural circuits and the wireless broadcasting of this information at
extremely high data rates to decoders for real-time recording and deciphering of neural
codes.
Bottom-Up Methods, Self-Assembly, and Chemical Patterning
Smaller-than-standard lithographic scales can be reached using self- and directed
assembly.65–68 Tremendous progress has been made in functionalizing a wide variety of
materials, including semiconductors, insulators, metals, glasses, nanoparticles, and porous
materials. With a single molecular layer, the chemical, physical, and biological properties of
materials can be controlled and tailored.
Given the need for more than electronic or optical function, it is critical to control the
exposed chemistry on devices. Tremendous advances have been made in the last 30 years in
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the chemical functionalization on a wide range of substrates.65–67 Such advances can be
applied both to guide assembly and to control biological and other interactions.
Likewise, nanoparticles and other nanostructures can be specifically functionalized so as to
target specific locations and to be stabilized there such as lodging themselves in cell
membranes.69,70 In this way, physical placement of nanostructures will not necessarily be
required, but instead reporting or post-mortem analyses can be used to determine the
absolute and relative locations of nanostructures used in BAM sensing. Potential uses of
nanoparticles and nanostructures are discussed further below.
In addition, functional molecules can be used to sense and to transduce potentials, pressure,
and specific aspects of chemical environments. We anticipate that artificial and hybrid
neurotransmitter receptors will be critical in reporting the local environment in the brain.
Tremendous opportunities exist if one can explore the 10 nm synapse scale to understand
dynamic neuro-transmission while simultaneously recording the activities of thousands of
neurons in a neural circuit. If nanostructures can be targeted to specific cell or synapse types
by means of chemical signatures on the cell surfaces, it may be possible to monitor and to
control the activities of neurons in cell-type-specific manners. We anticipate that, ultimately,
such measurements could also be used in feedback circuits to control diseases in which local
chemistries play critical roles, such as Parkinson’s and schizophrenia. The implications of
developing these and other BAM technologies are significant.
Development of Nanoscale Tools for Neuroscience
In light of the advances in resolution of these top-down and bottom-up miniaturization
strategies, the endeavor toward matching the sizes of devices that measure and control
neuronal activity with the sizes of individual neurons is compelling and appears inevitable.
Below, we enumerate a few of the areas in which these contributions are anticipated.
Electrophysiology
The major obstacles that presently limit the use of nanoscale probes are the engineering
challenges of building efficient power and communications systems to interface such neural
probes with the outside world and at the same time avoid tissue damage and undesirable cell
responses. Whether quantum dots or wafer-bonded microsystems are used, it is important to
avoid heating and toxicity in the vicinity of the measurement probes. The most important
physical barrier that limits the sizes of intracellular neural interfaces is the impedance of the
electrodes—whether these are on nano-particles embedded within cell walls or on more
conventional electro-physiological patch-clamp systems. For extracellular recording, the
impedance is even more important, as it determines signal-to-noise characteristics and, thus,
the sensitivities of the neural probes. The sensitivity toward neuronal signals depends on the
impedance, which can then be transduced to measurement devices outside of the brain.
Brain Activity Mapping with Nanofabricated Electrode Arrays
One of the technologies that can greatly facilitate brain activity mapping is the extracellular
microelectrode, which can resolve single-neuron firing in vivo without penetrating the cell.
Once inserted in the brain, the detection range of this type of sensor is typically limited to
neurons whose cell bodies are closer than ~50 μm from the microelectrode surface.23,71,72
Thus, in order to construct systems-scale views of brain function from such measurements,
the objective has been to increase the number and density of recording sites. Scaling up
these device attributes has been spurred by parallel advances in electronic instrumentation
for reading out signals via low-noise amplifiers, multiplexers, and wireless transmitters24–30
and performing basic signal processing functions on-chip to reduce the burden of data
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collection.31,32 Innovations in microelectrode manufacturing techniques have made it
possible to deploy simultaneously nearly 1000 measurement sites distributed across several
cortical areas of the same animal, allowing the firing patterns of hundreds of neurons to be
monitored in parallel.33 Leveraging micro- and nanofabrication technology raises the
prospect for creating vastly greater numbers of electrodes and smaller, less invasive
implantable devices.34–37 A promising category of these micromachined devices is the
planar electrode array, which is patterned on a crystalline,38,73 ceramic,39 or polymer74,75
support structure (Figure 1). Positions of micro-electrodes on these thin penetrating shafts
and spacing between two or more shafts can be tailored to simplify targeting of multiple
anatomical areas or subregions in tandem.76–78 The measurement of neuronal activity with
three-dimensional (3D) microelectrode arrays represents a major advance in brain activity
mapping techniques, by providing a tool to probe how intra-and inter-regional neural circuits
behave cooperatively to compute information. We envision scaling up this 3D architecture
to sample arbitrarily complex networks.
Advantages and Challenges of Electrode-Array-Based Mapping
Approaches
The use of implantable electrodes is complementary to optical-based brain activity mapping:
Electrodes can access deep brain structures that are challenging to reach with optical
methods; they do not require labeling cells with a dye; and they offer higher sampling speed
than voltage or calcium indicators (although advances in optical recording techniques are
circumventing many of these issues).7,79,80 Furthermore, the manufacturing processes used
in voltage-sensing electrode development can translate to other modes of interrogating
neuronal activity, such as chemical sensors.81,82
Electrodes also present two major challenges for brain activity mapping. First, as they
measure extracellular electric fields from all nearby active neurons, deriving single-unit
information from these signals is not trivial,83 and a fast, automated “spike sorting”
algorithm for handling data from a large number of electrodes receiving correlated signals
remains elusive. Even after spike sorting is successful, extracellular signals cannot directly
differentiate the origins of action potentials at the level of genetically specific neuronal
subpopulations. One approach that partially addresses this limitation is to rely on indirect
identification methods such as extracellular action potential shape, spike time
characteristics, and pharmacological response. This may be valuable for identifying cells
along broadly defined categories, such as pyramidal neurons versus interneuron84 or
dopaminergic versus nondopaminergic.85 However, this method is not without pitfalls.86
Perhaps an early goal of the BAM electrode technology effort would be to catalog
exhaustively extracellular electrophysiological markers of genetically identified neuronal
sub-populations to lend greater validity to this indirect approach. Alternatively, a more
direct way of identifying neurons is by probing their responses to a gene, region, or
pathway-specific pharmacological or optogenetic modulator of activity.87–89
Microfabricated neural probes that can record activity and deliver drugs or light have been
developed and can help address this issue.90–94
New developments in nano–bio interfacing and 3D microfabrication techniques might
provide the means to overcome some of the limitations of planar microelectrode-based
extracellular electrophysiology. Nanoscale needle electrodes (Figure 2) can provide high-
fidelity electrophysiological interfaces to cardiomyocytes95,96 and mammalian neurons,97
with clear cell-to-electrode registry. These electrodes can even perform intracellular
recording and stimulation of neurons in a highly scalable fashion in vitro and ex vivo.97 One
possibility is to couple these nanoscale electrodes together with the modular 3D brain
interfacing technology that has recently been developed.98 These 3D devices, which are
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assembled from lock-and-key digitally designed elements, enable positioning of electrodes
with micrometer-scale precision yet can extend a centimeter or more in linear dimension and
deliver and collect information from thousands of points throughout the brain. While the
technology was originally developed for brain-wide optogenetic mapping,99 it can also be
used for practically any sensing and stimulation modalities, including electrodes, chemical
sensors, and camera pixels. When coupled together, the nanoscale electrodes and 3D
interface system will enable high-precision observation of synapse- and subthreshold-
resolution neural activity in neurons throughout complex intact brain circuits, thereby
addressing many of the early technological goals of the BAM project.
Flexible and active electronics offer another potential option for interfaces to neural circuits
and the brain.100–106 Significant progress has been made in the areas of ultrathin, flexible,
light, biocompatible circuits. Hundreds of contacts to the brain can be made on double-sided
active semiconductor nano-membrane electronics transferred onto silk or other flexible
substrates (Figure 3).106 Early examples of these devices already integrate electrodes,
sensors, amplifiers, and multiplexers at the hundreds- to thousands-of-devices scale and
have been tested in vivo. Substrates and other parts can be made to be biodegradable/
bioresorbable.105 The possibilities of folding these flexible structures may enable less
invasive means of introduction.
An additional challenge is electrode longevity, which is critical for ensuring the success of
brain machine interfaces and long-term studies linking brain activity to behavior.105,107–109
The ability to record units from chronically implanted microelectrodes degrades on the time
scale of days to years,110–112 and the mechanisms underlying this degradation have not been
fully determined. On short time scales, disruption of the blood-brain barrier and cellular
milieu from the stab wound may negatively affect recording performance113–115 but do not
appear to prohibit high-yield measurements.116 On longer time scales, this injury triggers a
cascade of molecular signaling events leading to a sustained inflammatory response around
the implant.117,118 A variety of approaches are being explored to mitigate signal-to-noise
reduction resulting from acute and chronic injury responses. Some of these include using
flexible or wireless interconnects to decouple the electrode from shearing forces caused by
brain micromotion in the skull,119,120 anti-inflammatory probe coatings,121,122 and
techniques to coax neurons to form stable interfaces with the implanted devices.123,124
Nanotechnology has the potential to augment these efforts significantly by enabling
extremely miniaturized sensors that have negligible adverse interactions with surrounding
neural tissue or vasculature.125 An important milestone in addressing electrode longevity
challenges could be a minimally invasive wireless nanoscale probe than can attach itself to a
single neuron and report its firing activity for greater than 1 year. Finally, many important
observations of brain activity can take place on short behavioral time scales of minutes or
hours. In this acute recording situation, the interface longevity issue is less critical than the
need to sample as many neurons as possible.126,127 This creates an intriguing opportunity to
pursue in parallel a different set of BAM tools for acute, ultra-large-scale electrophysiology
and tools for chronic, ultrastable electrophysiology. Insights from these different
technological development strategies could be combined in the final embodiment of the
BAM electrode initiative.
Nanoparticle Labeling and Reporting
Over the past few decades, the development of more reproducible and accurate tools for
monitoring and controlling chemical reactions has enabled the synthesis of an enormous
variety of nanoparticles, nanomaterials, and nanostructures, with controlled composition,
organization, shape, and functionalization. Examples include the evolution of fullerenes,
carbon nanotubes, and graphene, materials systems in which desirable electrical and
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mechanical attributes can be obtained by careful vapor deposition of carbon with accurate
control over geometry and bonding. Similarly, carefully controlled chemical reactions have
led to light-emitting materials defined in nanoparticles whose surfaces can be passivated to
ensure high luminescence efficiencies. Today, quantum dots with emission wavelengths
spanning the spectrum from ultraviolet to infrared can be found and are used for optical
imaging, as efficient light sources, for photovoltaic energy harvesting systems, and for
quantum physics experiments. As these particles are small enough to quantum-confine
carriers in the semiconductor materials from which they are made, their geometries
determine the blue shift in the band gap of the light emitter, and their emission wavelength
can be tuned geometrically by changing their size or shape. Moreover, as the dimensions of
these nanoparticles are small, it is possible to build up extremely large electrical or optical
fields in quantum dots and wires, leading to switching and sensing opportunities far beyond
simple photoluminescent light sources.128 For imaging purposes, nanoparticle surfaces have
been functionalized with specific binding chemistries to target and highlight local
chemistries.129,130 Unlike more conventional organic dye molecules, quantum dots are less
subject to many of the stability problems that can plague fluorophores, such as
photobleaching and oxidation. We can also envision nanodevices with active optoelectronic
properties, so that they become self-powered neural signal transmitters, perhaps tapping into
the brain’s metabolic pathways for operating power.
Chemical Measurements in the Brain
Direct chemical measurements can be made in the brains of live, behaving animals with
probes that extract analytes (e.g., microdialysis)131–134 or extracellular fluid135 or that take
measurements locally and directly (e.g., electrochemical measurements for electroactive
compounds such as dopamine).12–17 Currently, the spatial and temporal resolutions for
chemical measurements based on extraction are ~100 μm and tens of seconds to minutes,
respectively, whereas local electrochemical methods can measure at the few micrometer
scale and hundreds of milliseconds, respectively.
Indirect in vivo measurements also can be made of nonelectrochemically active
neurotransmitters (e.g., glutamate, acetyl choline) and other molecules by coupling
enzymatic reactions that produce electrochemically active products to sensors.136–139 These
biosensor methods have somewhat lower spatial and temporal resolution than direct
electrochemical sensors but could be coupled to the parallel platforms envisaged for the
BAM project. Likewise, as platforms are developed for this project, artificial receptors will
be developed140,141 and coupled for electronic measurements142,143 to sense the spatial and
temporal profiles of neurotransmitters in vivo.
New Imaging Tools
Optical interrogation of populations of neurons in intact animals critically depends on two
things: the ability to deliver light efficiently to the brain and the ability to get light out of the
brain. These problems are difficult in the single-cell context and become more challenging
when parallel simultaneous measurements are required. Today, both conventional
fluorescence microscopy and nonlinear optical microscopy play important roles in imaging
neural activity in behaving animals.144 High-speed, miniaturized epifluorescence
microscopes (<2.0 g mass) have been fabricated from mass-producible optical parts, such as
light-emitting diodes (LEDs) and nanofabricated semiconductor sensors (Figure 4).145 An
adult mouse can readily bear such a microscope on the head during active behavior, which
routinely allows imaging of calcium dynamics in >1000 neurons per mouse (Figure 5).146
To reach deep brain areas, this approach relies on optical needles based on microlenses.
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Alternatively, to maintain single-cell precision and localized excitation volumes within
tissue that scatters light, one can use nonlinear optical microscopies in the near-infrared
(NIR) region because of higher transmission relative to visible wavelengths.147
Despite the reduced scattering of NIR photons compared with visible photons, the
exponential loss of ballistic photons in scattering media greatly limits our ability to penetrate
deep within the brain.148 One strategy to increase image contrast and total depth is to
increase the nonlinearity of the excitation process, which can dramatically reduce
background signal. This can be done directly, as in the case of long-wavelength three-photon
fluorescence microscopy,149 or through cascaded nonlinearities enabled by new
fluorophores.150 Both techniques still require delivery of ballistic photons and suffer in
scattering media. However, in the past decade, there have been notable improvements in the
ability to deliver light deep within complex media.151,152 In these experiments, the
wavefront of the incoming light beam is dynamically modified to compensate effectively for
the aberrations and scattering bodies in the sample. The more complex the media, the more
complex the wavefront modifications required for correction, and the greater the number of
iterations of corrections that will be required to compensate. The most dramatic examples
have been performed using single-photon illumination with high-speed deformable mirror
devices (DMD), which can modulate the wavefront at rates of ~20 kHz, and have achieved
near diffraction-limited performance imaging through a dynamically changing turbid
environment. The same methods have been used successfully in directing light and imaging
through multimode fibers,153 offering the potential of minimally invasive imaging of deep
internal structures. Unfortunately, the same successes have not yet been achieved with
nonlinear microscopies, as the modulation devices are significantly slower. This difference
occurs because, in order to maintain excitation efficiency, phase-only modulators are used,
and the best devices for this purpose are phase-only liquid-crystal spatial light modulators
where the liquid crystal properties limit speed to frame rates up to 500 Hz. Within the
materials/nanoscience communities, there is a tremendous opportunity for applying solid-
state or polymer technologies to address this problem. For optical switching, many materials
can provide fast phase modulation, with switching times in the GHz. The development of a
high resolution (>1 Mpixel) phase modulator array might enable deep-tissue optical
imaging. These significantly higher speeds make digital/optical phase conjugation or
compressive sampling more powerful when working with scattering media and enable
deeper imaging in dynamically changing samples with temporal resolution below the
decorrelation time.
High-resolution, high-speed arrays would also enable the creation of holograms for multisite
excitation throughout the volume, which is a possible means of attaining high-speed, parallel
measurements. Temporal coding of individual target sites might also enable high-speed,
parallel measurements. However, in nonlinear optical imaging, holograms that illuminate
large volumes of tissue have the notable disadvantage of reducing the instantaneous light
intensity at any one location. In comparison, time-multiplexing schemes, such as those using
acousto-optic deflectors, have the distinct advantage that they keep the instantaneous
illumination high. Furthermore, as the focal point moves deeper into the sample, the emitted
photons scatter during escape. When the focal depth increases beyond ~10 scattering
lengths, the escaping photons lose memory of their origins and approach the photon
diffusion limit. Here, the effective source size of the illuminated object scales proportionally
with the depth of the target, making simple imaging insufficient to recover the individual
signals. With fast modulation of the hologram, one could beat individual targets at different
rates, enabling temporal encoding of the multiplexed illumination such that unique
signatures exist for each overlapping target.
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Along with improvements in the input of light to the system, we also need to improve the
detectors measuring light coming out of the sample. Custom-designed microcavities and
photonic crystals offer the possibility of extremely sensitive detection of the local
environment and activity.18 Additionally, these microcavities can be used to enhance the
brightness and spectral properties of coupled fluorophores, through the Purcell effect.154
Large fields of view (FOVs) are required to collect emitted photons efficiently from deep
within the samples. Here, there are opportunities to harness the nanoscale electronics
community to develop large FOV multichannel avalanche photodiode (APD) arrays that
would offer significant multiplexing advantages over traditional detectors. The high time
resolution and channel independence provided by such arrays would be well-suited to
demultiplex complex signals arising from deep in vivo multisite excitation.
Many cellular structures regulating neuronal activity (including synapses, tight junctions,
actin, microfilaments, and receptor complexes) are composed of densely arrayed
components with spacings that are complex and far below the diffraction limit (Figure 6).
New optical imaging tools with nanoscale resolution, such as PALM155 and STORM,156 are
helping scientists explore these nanoscale objects within cells. These techniques can resolve
structures in microscopic images with ~20 nm or better spatial precision. They thus promise
to help uncover the organizational principles of macromolecular complexes within
specialized cells of the nervous system. As an example, recent work employing these
techniques has revealed the dynamic behavior and organization of the actin cytoskeleton
inside cells, which is relevant for understanding how neurons probe their involvement
during neuronal outgrowth and in response to injury157 and how they differentiate axonal
processes.158 These techniques also permit characterization of receptor clustering and
stoichiometry at the plasma membrane under diverse conditions159,160 as well as protein
organization inside synapses,161 which are critical for understanding how synapses respond
to changes in neuronal activity.
Optogenetics
Brain activity mapping is tightly linked to optogenetics—the use of light to control well-
defined events within targeted elements of intact biological systems (reviewed in ref 162)—
in several important ways (Figure 7).163 Control of brain activity in a precise, targeted, high-
speed manner (e.g., as enabled by optogenetics with microbial opsin genes,89,162,164–166
which encode light-activated channel and pump regulators of transmembrane ion
conductance) in principle will allow assessment of the causal significance of brain activity
patterns observed with recording or imaging. In this way, activity mapping becomes not
simple, passive observation of activity correlating with behavior but observation coupled
with insight into causal significance—a key distinction.
Further, optogenetics enables the identification of cellular genetic identity by
“phototagging”. This method could help liberate high-speed readouts of neural activity from
the need to be intrinsically genetically targeted. For example, multiunit electrical recording
itself carries essentially no information on the genetic phenotype of the neurons generating
the recorded spikes; however, when linked to phototagging (in which a genetically encoded
control tool is introduced to drive spiking), corresponding electrical spikes with their own
unique waveforms are observed after light pulse initiation at sufficiently brief intervals and
can in some cases thereafter be inferred to belong to the genetically targeted class.167 In this
way, optogenetics can enhance and enable pure activity mapping itself.
Optogenetic tools are themselves nanoscale devices that can be engineered for new classes
of brain activity mapping function, building on molecular structure–function relationships.
Not only can many different kinds of ion flow, spectral responses, and kinetics be achieved
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through directed engineering,162–164 but also fundamentally new classes of function can
arise from this kind of work (e.g., turning a microbial opsin into a voltage sensor for activity
mapping9). Moreover, the success of optogenetics has inspired discussions of other possible
classes of control (e.g., magnetogenetics, acoustogenetics) in which other modalities of
energy delivery would be captured by distinct classes of engineered, targetable-molecular-
energy antenna-like elements expressed in specific classes of cells.163,168,169
Optogenetics has already found widespread utility in mapping circuits causally involved in
both normal function and in the elicitation and correction of disease-related phenomena
including anxiety, depression, fear memory, parkinsonism, and social dysfunction.170–174
We have pointed out that additional technologies also need to be developed further for this
approach to reach its full potential:20 (1) methods for determination of global (brain-wide)
wiring diagrams of cells that are observed and controlled in vivo; (2) volumetric, genetically
targeted methods both to visualize and to control activity within intact tissue;98,175,176 and
(3) non-optical methods that leave a recoverable trace of activity within cells to sidestep the
light-scattering problem, which could involve a gene encoding a designer polymerase
transduced into a genetically targeted subset of neurons,19–21 especially if the polymerase
were engineered for increased error rate in elevated Ca2+,20 which can track neural activity
patterns at high speeds, even in the nucleus.177 Together, these concepts highlight how
optogenetics approaches could address key goals of brain activity mapping but require
integration with other established and novel technologies.
Biological Hybrids and Synthetic Biology
Functional metagenomics can survey the biosphere for extraordinary new nanocomponents
(typically proteins), which, via protein engineering and laboratory selections, can be fused
and optimized to make complex systems very much at home in nanometer- to centimeter-
scale biological networks. These bio-nano “parts” can include not only fluorescent ion
sensors and light-responsive channels (vide supra) but also light-emitting sensors
(luciferases) and fluorescent voltage (action potential) indicators like Archaerhodopsin 3
(Arch) with an optical signal-to-noise ratio >10 and 41 ms time response.9
Synthetic biology can potentially provide hybrid system interfaces with inorganic fabricated
components, including building or bridging 3D optical fiber arrays91,98 to provide
effectively high optical surface area and multiplexing—for example, thin natural light wave
guides in glass sponges.178 Building optical fibers around the extensive brain vasculature
might be less disruptive than inserting them as solid arrays from the surface (or could
complement such arrays). Dynamic viral capsids, DNA nanorobots,179 and/or engineered
cells can navigate the blood-brain barrier, and cerebrospinal fluid or trans-synaptic clefts180
can provide targeting specificity for brain activity input/output and/or neuronal connectivity
data. Polymerases can provide analog-to-digital “ticker tape” recording sensors for light,
ATP (e.g., in active synapses), and ions.1,181 Fluorescent in situ sequencing (FISSEQ)182 or
hybridization (FISH)183 could enable alignment of electrode or optical fiber arrays with the
anatomical connectome, RNA transcriptome, and ticker tapes all in one set of serial sections
—reminiscent of the Allen Brain atlas,40 but without the artifacts (and cost) of aligning
“similar” regions from numerous different brains. Insertion of (up to billions of) synthetic
DNA barcodes is helpful not only for neuronal lineage analysis184 and synaptic
connectivity180 but also for integrating the multidisciplinary brain data (vide supra) with the
controlled sensory inputs and behavioral outputs in BAM experiments on individual animals
over diverse (normal and pathological) genetic and pharmacological backgrounds.
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Connecting Neuroscience at the Molecular and Dynamical Systems Levels
Brain activity mapping electrode technology will enable scientists and clinicians to generate
an inherently different type of data set than what genomic sequencing or brain-wide gene
expression maps provide, which are static or slowly evolving snapshots of molecular
information. In contrast, BAM technology will reveal an extremely complex choreography
of neuronal activation that is constantly in flux. One of the major challenges for BAM
technology development is to unify this electro-physiological view with the equally complex
and important molecular landscape of the brain. After all, behavior, learning, and cognition
require synergy between chemical neurotransmission, biochemical reactions, and electrical
impulses. It is critical that, in addition to enabling recordings from unprecedentedly large
numbers of neurons, BAM also enhances these incredibly powerful complementary levels of
analysis. The development of multifunctional nanoscale probes that can simultaneously
record and pharmacologically or optogenetically perturb molecularly defined neurons, with
high spatial and temporal precision, may be a necessary step in providing critical tests of
proposed mechanisms and theories of neural circuit and brain function.
Theory, Modeling, and Computation
One of the goals of brain activity mapping is to provide large data sets to be used in
modeling and developing theories of the emergent properties of neural circuits and detailed
connections between different levels of operations and hierarchical abstractions, including
natural, synthetic, and practical spatiotemporal patterns. Likewise, technology to be
developed can provide critical tests of these models and theories by active interaction with
neural circuits. We anticipate that open access to these data sets will draw worldwide
interest in and attention to the task of developing this understanding. The data sets will be
large but comparable to those being produced by current astronomical observations, in
genomics, and other areas. As in these other large data sets, compression and leveraging
tools developed in the field of sparsity will likely be used heavily.185
Equally important for achieving a deeper understanding of brain function is the comparable
development of a conceptual framework and mathematical theory for brain activity in high-
dimensional spaces. Current theories of brain function based on recordings from single
neurons are limited in scope. Population codes have been deduced by combining recordings
from many neurons recorded separately. Observing population codes as they unfold in real
time should reveal deeper and dynamically shifting relationships between the neurons and
the ongoing processing occurring in dense brain circuits. The population dynamics of the
neural ensemble carries a far richer representation of sensory stimuli and actions.
Simulations of brain activity will be another important tool for refining our ideas about brain
function, based on experimental recordings and additional constraints from the cellular and
molecular levels of brain organization. The new methods for recording and manipulating
neurons, including intracellular biochemical pathways, will enable us to design experiments
that test competing hypotheses. For example, the responses of neurons in the visual cortex
have latencies that range from 20 to 100 ms, but we have the impression of a single moment
when a stimulus flashes. Is there a deeper neural correlate among a large population of
neurons that is more closely associated with our subjective impression of time? How do we
store and recall the temporal structures that occur in music? The BAM Project may bring us
closer to answering ultimate questions about how we think and make decisions, which
involve the coordinated activity in large numbers of neurons widely distributed throughout
the human brain. Understanding the principles of neural computation will also lead to new
devices based on these principles.
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PROSPECTS
In these and other areas, there are tremendous opportunities for nanoscience and
nanotechnology to contribute to neuroscience. We have collected answers to frequently
asked questions on the BAM Project as this exciting proposal now stands. We hope that the
BAM Project will bring the past decade’s national and international investments in science,
technology, and people in nanoscience and nanotechnology to bear on important and
challenging problems in brain science.
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Figure 1.
Nanofabricated planar electrode array for high-density neuronal voltage recording. False-
color SEM image of a portion of a 64-channel array patterned on a silicon substrate. Scale
bar = 50 μm. Modified from ref 37. Copyright 2011 Du et al.
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Figure 2.
Three-dimensional nanoelectrode array (3D-NEA) for in vivo interrogation of neuronal
networks. (a) Scanning electron microscope (SEM) image of the nine silicon nanoneedles
that constitute the active region of a 3D-NEA. Dimensions of the nanoneedle electrodes are
designed to facilitate single-cell intracellular electrical coupling. False colors show metal-
coated tips (gray) and insulating silicon oxide (blue). Reprinted with permission from ref 97.
Copyright 2012 Nature Publishing Group. (b) Scanning electron micrograph of a rat cortical
cell (3 days in vitro, false colored yellow) on top of an electrode pad (false colored blue).
Reprinted with permission from ref 97. Copyright 2012 Nature Publishing Group. (c)
Stimulation and recording of rat cortical neurons. Upper traces show that action potentials
(blue: measured by a patch pipet) could be reliably stimulated by voltage pulses applied to
the nanoelectrodes (magenta). Similarly, lower traces show that the nanoelectrodes can
record action potentials (magenta) stimulated by a patch pipet (blue). Reprinted with
permission from ref 97. Copyright 2012 Nature Publishing Group. (d) Scanning electron
micrograph of a representative 3D brain-interfacing device consisting of 24 probes, each
containing arrays of active sites distributed along their length. Inset: optical image of the 3D
probe array. Reprinted with permission from ref 98. Copyright 2012 Optical Society of
America.
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Figure 3.
(a) Flexible, high-density active electrode arrays composed of semiconductor
nanomembrane electronics transferred onto polymer substrates were placed on the visual
cortex of a cat brain or (b) into the interhemispheric fissure (inset). Reprinted with
permission from ref 105. Copyright 2011 Nature Publishing Group.
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Figure 4.
Miniature, mass-producible fluorescence microscope. (a) Cross-sectional schematic of the
microscope design. Purple and green arrows show excitation and emission pathways,
respectively. (b) Microscope (1.9 g) shown fully assembled with its LED light source,
micro-optics, and camera. Insets show, clockwise from bottom-left, the fluorescence filter
cube with excitation and emission filters and dichroic mirror; the mounted camera chip; and
the LED light source. Scale bars for a, b, and insets are 5 mm. Reprinted with permission
from ref 145. Copyright 2011 Nature Publishing Group.
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Figure 5.
Ca2+ imaging in >1200 CA1 pyramidal cells in freely moving mice. (a) Integrated
microscope (Figure 4) is equipped with a microendoscope and images CA1 neurons
expressing the Ca2+ indicator GCaMP3 via the Camk2a promoter. The base plate and
microendoscope are fixed to the cranium, for repeated access to the same field of view.
Reprinted with permission from ref 146. Copyright 2013 Nature Publishing Group. (b) 1202
CA1 pyramidal cells (red somata) identified by Ca2+ imaging in a freely moving mouse,
atop a mean fluorescence image (green) of CA1. Vessels appear as dark shadows. Image
courtesy of Yaniv Ziv and Lacey Kitch, Stanford University. (c) Example traces of Ca2+
dynamics from 15 cells. Scale bars: 5% ΔF/F (vertical) and 10 s (horizontal). Reprinted with
permission from ref 146. Copyright 2013 Nature Publishing Group.
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Figure 6.
Actin retrograde flow rates at the leading edge of a PtK1 cell. The photoactivatable protein
tdEos tagged to actin was expressed in PtK1 cells. Individual molecules were visualized
through photoactivation with ultraviolet light. They were then tracked over time to reveal
movement of individual actin molecules within actin filaments at the edge of the cells. A
flow map of rates of actin filament movement from the cell surface is shown. Vector colors
reflect flow speed (color bar), and arrows reflect direction. The scale bar is 10 μm.
Reproduced with permission from ref 157. Copyright 2011 Nature Publishing Group.
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Figure 7.
Brain activity mapping may be enabled, in part, by optogenetic preparations as shown here
in a freely moving mouse; green light is delivered to deep or superficial brain areas via fiber
optics. Optogenetic control of microbial protein-expressing targeted neurons enables (1)
determination of causal significance of activity patterns; (2) in some cases, phototagging
identification of cells from which electrical spikes are recorded; and (3) in some
preparations, imaging of neural responses to control or stimulation. Advances in
computational optics and nanoscale device engineering will further enable delivery of
complex spatially modulated light patterns to the target tissue. Figure adapted from Inbal
Goshen and Karl Deisseroth, Stanford University/HHMI.
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